By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has listed certain of its liquid chromatography and mass spectrometers as Class I medical devices with the US Food and Drug Administration.

The instruments that were listed are the company's Infinity Series 1200 LC platforms and 6000 Series mass specs. Class I classification is for devices that pose the least risk to patients and Class I devices are the least regulated under FDA's three classifications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.